07.16.13
James Pusey, M.D., has been appointed president and general manager of WuXiPRA. Dr. Pusey has more than 25 years of experience in medicine, international clinical trial management, CRO services, and global pharmaceutical sales, marketing, and clinical operations.
Prior to joining the company, Dr. Pusey was founding chief executive officer of Theorem Clinical Research, where he served as president and chief executive officer, executive chairman, and board director from 2009. Previously, Dr. Pusey served as senior vice president and general manager of global clinical development at MDS Pharma Services, and served as president and chief executive officer of Orthologic, Inc.
"We are pleased that Dr. Pusey has joined the company," said Colin Shannon, president and chief executive officer, PRA. "His global experience in the CRO market will be an asset to WuXiPRA. With clinical trials continuing to expand in China, having Dr. Pusey onboard will allow us to establish a stronghold in the region."
Prior to joining the company, Dr. Pusey was founding chief executive officer of Theorem Clinical Research, where he served as president and chief executive officer, executive chairman, and board director from 2009. Previously, Dr. Pusey served as senior vice president and general manager of global clinical development at MDS Pharma Services, and served as president and chief executive officer of Orthologic, Inc.
"We are pleased that Dr. Pusey has joined the company," said Colin Shannon, president and chief executive officer, PRA. "His global experience in the CRO market will be an asset to WuXiPRA. With clinical trials continuing to expand in China, having Dr. Pusey onboard will allow us to establish a stronghold in the region."